Back Ground: Hemifacial spasm is one of movement disorder case that commonly found in daily clinical practice. Epidemiological data are very limited, the average prevalence is 11 per 100,000 population, 14.5 per 100,000 in women and 7.4 per 100,000 in men. In Germany, the estimated prevalence is 8000 to 9000 peoples.1 The incidence of women is more than that of men with a ratio of 2:1. Based on Yaltho and Jankovic study in 2011, out of 215 patients, the ratio of men to women was 1:1.8.2 One study in Indonesia also reported that most of the subjects were female (64.7%).3 Treatment with botulinum toxin injections is preferred to microvascular decompression surgery therapy, but this injection is only effective in a few months and quite expensi...
This paper appraises an article published in Acupuncture in Medicine in 2018 by one student and two ...
Primary hemifacial spasm is a hyperactive cranial nerve syndrome. The cause is always a neurovascula...
Jost WH, Laskawi R, Palmowski-Wolfe A, Spittau B, Urban PP. Botulinumtoxin – Therapie des Spasmus he...
Treatment with botulinum toxin injections is preferred to microvascular decompressionsurgery therapy...
Background : Hemifacial spasm is a common movement disorder in Thailand. Botulinum toxin has been in...
Background: Hemifacial Sapsm (HFS) is a common movement disorder in Thailand. Botulinum toxin type A...
Spasticity is a common symptom in patients with a history of stroke which can alter a variety of dai...
Context: Spasticity in neurological disorders (i.e. stroke patients and cerebral palsy) is positivel...
Hemifacial spasm is usually treated with botulinum toxin A (BTX-A) injections, a proven symptomatic ...
Myofacial trigger points and other pain syndromes can be treated with dry needling (DN), a therapeut...
Background: Botulinum toxin (BTX) injections are accepted as safe and efficacious in the treatment o...
Spasticity is one of the main complications of a stroke. This double-blind, randomized controlled tr...
Spasticity or increase in muscle tone is one of the problems following stroke. Due to this increase ...
Background Blepharospasm and hemifacial spasm are debilitating conditions that significantly impact ...
Botulinum toxin A (BTA) is considered an effective treatment of blepharospasm and hemifacial spasm, ...
This paper appraises an article published in Acupuncture in Medicine in 2018 by one student and two ...
Primary hemifacial spasm is a hyperactive cranial nerve syndrome. The cause is always a neurovascula...
Jost WH, Laskawi R, Palmowski-Wolfe A, Spittau B, Urban PP. Botulinumtoxin – Therapie des Spasmus he...
Treatment with botulinum toxin injections is preferred to microvascular decompressionsurgery therapy...
Background : Hemifacial spasm is a common movement disorder in Thailand. Botulinum toxin has been in...
Background: Hemifacial Sapsm (HFS) is a common movement disorder in Thailand. Botulinum toxin type A...
Spasticity is a common symptom in patients with a history of stroke which can alter a variety of dai...
Context: Spasticity in neurological disorders (i.e. stroke patients and cerebral palsy) is positivel...
Hemifacial spasm is usually treated with botulinum toxin A (BTX-A) injections, a proven symptomatic ...
Myofacial trigger points and other pain syndromes can be treated with dry needling (DN), a therapeut...
Background: Botulinum toxin (BTX) injections are accepted as safe and efficacious in the treatment o...
Spasticity is one of the main complications of a stroke. This double-blind, randomized controlled tr...
Spasticity or increase in muscle tone is one of the problems following stroke. Due to this increase ...
Background Blepharospasm and hemifacial spasm are debilitating conditions that significantly impact ...
Botulinum toxin A (BTA) is considered an effective treatment of blepharospasm and hemifacial spasm, ...
This paper appraises an article published in Acupuncture in Medicine in 2018 by one student and two ...
Primary hemifacial spasm is a hyperactive cranial nerve syndrome. The cause is always a neurovascula...
Jost WH, Laskawi R, Palmowski-Wolfe A, Spittau B, Urban PP. Botulinumtoxin – Therapie des Spasmus he...